| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594386 | American Heart Journal | 2017 | 8 Pages |
Abstract
In this secondary analysis of the RELAX-AHF trial, baseline characteristics suggest that daytime-presenting patients may have more gradual worsening of chronic HF. Patients with AHF who presented at night had less risk for 180-day CV death, but similar risk for 60-day CV death or rehospitalization and symptom improvement for patients who presented during the daytime.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter S. Pang, John R. Teerlink, Leandro Boer-Martins, Claudio Gimpelewicz, Beth A. Davison, Yi Wang, Adriaan A. Voors, Thomas Severin, Piotr Ponikowski, Tsushung A. Hua, Barry H. Greenberg, Gerasimos Filippatos, G. Michael Felker, Gad Cotter,